307 related articles for article (PubMed ID: 19077561)
1. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan.
Ishiguro S; Inoue M; Tanaka Y; Mizokami M; Iwasaki M; Tsugane S;
Eur J Cancer Prev; 2009 Feb; 18(1):26-32. PubMed ID: 19077561
[TBL] [Abstract][Full Text] [Related]
2. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).
Inoue M; Kurahashi N; Iwasaki M; Tanaka Y; Mizokami M; Noda M; Tsugane S;
Cancer Causes Control; 2009 Jul; 20(5):741-50. PubMed ID: 19115074
[TBL] [Abstract][Full Text] [Related]
3. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
Inoue M; Yoshimi I; Sobue T; Tsugane S;
J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Arakawa T; Fujimori M
J Med Virol; 2010 Apr; 82(4):539-45. PubMed ID: 20166172
[TBL] [Abstract][Full Text] [Related]
5. Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population-based cohort study (JPHC Study).
Ishiguro S; Inoue M; Tanaka Y; Mizokami M; Iwasaki M; Tsugane S;
Cancer Lett; 2011 Jan; 300(2):173-9. PubMed ID: 21035947
[TBL] [Abstract][Full Text] [Related]
6. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
7. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
J Hepatol; 2009 Apr; 50(4):729-35. PubMed ID: 19232448
[TBL] [Abstract][Full Text] [Related]
10. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
11. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
Wu CF; Yu MW; Lin CL; Liu CJ; Shih WL; Tsai KS; Chen CJ
Carcinogenesis; 2008 Jan; 29(1):106-12. PubMed ID: 17999990
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Ohata K; Hamasaki K; Toriyama K; Matsumoto K; Saeki A; Yanagi K; Abiru S; Nakagawa Y; Shigeno M; Miyazoe S; Ichikawa T; Ishikawa H; Nakao K; Eguchi K
Cancer; 2003 Jun; 97(12):3036-43. PubMed ID: 12784339
[TBL] [Abstract][Full Text] [Related]
15. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ
Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326
[TBL] [Abstract][Full Text] [Related]
16. Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Suruki R; Hayashi K; Kusumoto K; Uto H; Ido A; Tsubouchi H; Stuver SO
Int J Cancer; 2006 Jul; 119(1):192-5. PubMed ID: 16432841
[TBL] [Abstract][Full Text] [Related]
17. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Ohata K; Hamasaki K; Toriyama K; Ishikawa H; Nakao K; Eguchi K
J Gastroenterol Hepatol; 2004 Jun; 19(6):670-5. PubMed ID: 15151623
[TBL] [Abstract][Full Text] [Related]
18. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan.
Iino S
Antivir Ther; 1998; 3(Suppl 3):143-6. PubMed ID: 10726064
[TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
